Murthy Mala 4
4 · Teladoc Health, Inc. · Filed Sep 3, 2025
Insider Transaction Report
Form 4
Murthy Mala
CHIEF FINANCIAL OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-08-29+2,641→ 135,084 total - Exercise/Conversion
Performance Stock Units
2025-08-29−2,641→ 5,285 total→ Common Stock (2,641 underlying) - Exercise/Conversion
Restricted Stock Units
2025-08-29−7,751→ 15,502 total→ Common Stock (7,751 underlying) - Exercise/Conversion
Common Stock
2025-08-29+9,233→ 152,068 total - Sale
Common Stock
2025-09-02$7.58/sh−12,846$97,437→ 142,385 total - Exercise/Conversion
Restricted Stock Units
2025-08-29−9,233→ 55,401 total→ Common Stock (9,233 underlying) - Exercise/Conversion
Restricted Stock Units
2025-08-29−3,163→ 18,979 total→ Common Stock (3,163 underlying) - Exercise/Conversion
Common Stock
2025-08-29+7,751→ 142,835 total - Exercise/Conversion
Common Stock
2025-08-29+3,163→ 155,231 total
Footnotes (6)
- [F1]Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F2]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F3]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
- [F4]The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F5]On March 3, 2023, the reporting person was granted 93,006 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F6]One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.